Alongside economic development, the specialty gases market is driven by an increasing need for reliable, accurate measurements of purity across a range of end-user markets, not least in the medical sector.
Due to the rising number of chronic diseases, the growing base of the elderly population, and the increasing demand for home healthcare, the medical gases market is growing rapidly and the needle is constantly moving on the product requirements.
In the US, this is particularly pertinent. Richard Craig, Technical Director for the Compressed Gas Association (CGA), was at the EIGA Winter Seminar in Brussels, Belgium in January (2019) and described the medical gas regulatory environment in the US and Canada. He explained how the CGA has been working with the US Food and Drug Administration (FDA) and Health Canada, with revised regulations and Unique Device Identifiers now in place covering good manufacturing practice, labelling, warehousing, registration and listing, and adverse event reporting for medical gases and devices.
... to continue reading you must be subscribed
